Chapin Davis’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.32M | Sell |
28,438
-1,276
| -4% | -$59.1K | 0.36% | 65 |
|
|
2025
Q1 | $1.81M | Buy |
29,714
+5,977
| +25% | +$365K | 0.62% | 36 |
|
|
2024
Q4 | $1.23M | Hold |
23,737
| – | – | 0.4% | 62 |
|
|
2024
Q3 | $1.23M | Buy |
23,737
+53
| +0.2% | +$2.74K | 0.4% | 63 |
|
|
2024
Q2 | $984K | Buy |
23,684
+1,140
| +5% | +$47.3K | 0.34% | 69 |
|
|
2024
Q1 | $1.22M | Buy |
22,544
+4,159
| +23% | +$226K | 0.45% | 51 |
|
|
2023
Q4 | $943K | Buy |
18,385
+214
| +1% | +$11K | 0.4% | 63 |
|
|
2023
Q3 | $1.05M | Sell |
18,171
-166
| -0.9% | -$9.63K | 0.5% | 51 |
|
|
2023
Q2 | $1.17M | Buy |
18,337
+32
| +0.2% | +$2.05K | 0.56% | 46 |
|
|
2023
Q1 | $1.27M | Buy |
18,305
+4,694
| +34% | +$325K | 0.66% | 35 |
|
|
2022
Q4 | $979K | Buy |
+13,611
| New | +$979K | 0.57% | 47 |
|